|
2025-04-30 |
2025-04-30 |
A
Achat
|
Myers Scott Dunseth
Administrateur non-exécutif
|
21 000
+8.1%
1,40
29 373 USD
|
21 000
+8.1%
|
1,40
|
29 373 USD
|
|
|
2025-02-12 |
2025-02-06 |
A
Achat
|
Bruns Ingmar
Chief Medical Officer
Dirigeant
|
20 000
+120.3%
2,28
45 656 USD
|
20 000
+120.3%
|
2,28
|
45 656 USD
|
|
|
2025-02-05 |
2025-02-03 |
V
Vente
|
Vultaggio Vincent
PAO and Interim PFO
Dirigeant
|
2 615
-1.4%
1,71
4 476 USD
|
2 615
-1.4%
|
1,71
|
4 476 USD
|
|
|
2025-02-05 |
2025-02-03 |
V
Vente
|
Lackner Mark
Chief Scientific Officer
Dirigeant
|
14 368
-2.7%
1,71
24 591 USD
|
14 368
-2.7%
|
1,71
|
24 591 USD
|
|
|
2025-02-05 |
2025-02-03 |
V
Vente
|
Paul Andrea
Chief Legal Officer
Dirigeant
|
13 230
-1.2%
1,71
22 643 USD
|
13 230
-1.2%
|
1,71
|
22 643 USD
|
|
|
2025-02-04 |
2025-01-31 |
A
Achat
|
Skvarka Jan
Administrateur non-exécutif
|
60 000
+67.0%
1,72
103 446 USD
|
60 000
+67.0%
|
1,72
|
103 446 USD
|
|
|
2025-02-04 |
2025-01-31 |
A
Achat
|
Walker Luke Nathaniel
Administrateur non-exécutif
|
14 200
+19.6%
1,76
24 966 USD
|
14 200
+19.6%
|
1,76
|
24 966 USD
|
|
|
2025-02-04 |
2025-01-31 |
A
Achat
|
EASTLAND JULIA MARIE
CEO & President
Administrateur exécutif
|
28 500
+inf%
1,73
49 345 USD
|
28 500
+inf%
|
1,73
|
49 345 USD
|
|
|
2025-01-03 |
2025-01-02 |
V
Vente
|
Lackner Mark
Chief Scientific Officer
Dirigeant
|
4 411
-2.3%
3,12
13 762 USD
|
4 411
-2.3%
|
3,12
|
13 762 USD
|
|
|
2024-10-04 |
2024-10-04 |
VP
Vente planifiée
|
Vultaggio Vincent
Principal Accounting Officer
Dirigeant
|
1 603
-4.5%
3,18
5 098 USD
|
1 603
-4.5%
|
3,18
|
5 098 USD
|
|
|
2024-05-31 |
2024-05-31 |
VP
Vente planifiée
|
Gallagher Cam
President, Interim CFO
Administrateur exécutif
|
9 597
-1.5%
11,98
114 972 USD
|
9 597
-1.5%
|
11,98
|
114 972 USD
|
|
|
2024-05-09 |
2024-05-09 |
V
Vente
|
HAUSMAN DIANA
Chief Medical Officer
Dirigeant
|
3 356
-0.9%
12,62
42 353 USD
|
3 356
-0.9%
|
12,62
|
42 353 USD
|
|
|
2024-02-12 |
2024-02-12 |
VP
Vente planifiée
|
Gallagher Cam
President
Administrateur exécutif
|
1 173
-0.2%
11,44
13 419 USD
|
1 173
-0.2%
|
11,44
|
13 419 USD
|
|
|
2024-02-12 |
2024-02-12 |
VP
Vente planifiée
|
Epperly Melissa B,
Chief Financial Officer
Dirigeant
|
2 573
-0.6%
11,44
29 435 USD
|
2 573
-0.6%
|
11,44
|
29 435 USD
|
|
|
2024-02-05 |
2024-02-02 |
V
Vente
|
Paul Andrea
Chief Legal Officer
Dirigeant
|
3 310
-2.2%
11,54
38 197 USD
|
3 310
-2.2%
|
11,54
|
38 197 USD
|
|
|
2024-02-05 |
2024-02-02 |
V
Vente
|
Lackner Mark
Chief Scientific Officer
Dirigeant
|
1 585
-0.8%
11,54
18 291 USD
|
1 585
-0.8%
|
11,54
|
18 291 USD
|
|
|
2024-02-05 |
2024-02-02 |
VP
Vente planifiée
|
Epperly Melissa B,
Chief Financial Officer
Dirigeant
|
8 669
-1.9%
11,54
100 040 USD
|
8 669
-1.9%
|
11,54
|
100 040 USD
|
|
|
2024-02-05 |
2024-02-02 |
VP
Vente planifiée
|
Gallagher Cam
President
Administrateur exécutif
|
11 552
-1.8%
11,54
133 310 USD
|
11 552
-1.8%
|
11,54
|
133 310 USD
|
|
|
2023-11-13 |
2023-11-13 |
A
Achat
|
Blackwell Kimberly
Chief Executive Officer
Administrateur exécutif
|
5 000
+2.0%
10,29
51 448 USD
|
5 000
+2.0%
|
10,29
|
51 448 USD
|
|
|
2023-11-13 |
2023-11-10 |
A
Achat
|
Johnson David Michael
Administrateur non-exécutif
|
17 000
+13.3%
9,88
167 943 USD
|
17 000
+13.3%
|
9,88
|
167 943 USD
|
|
